Skip to content
The Policy VaultThe Policy Vault

Lyrica (pregabalin)CareFirst (Caremark)

Postherpetic neuralgia

Preferred products

  • gabapentin immediate-release

Initial criteria

  • The request is for one of the listed drugs
  • If Lyrica oral solution—patient has difficulty swallowing oral solids OR requires a dose not obtainable via capsules
  • Patient experienced inadequate response, intolerance, or contraindication to gabapentin immediate-release

Reauthorization criteria

  • Request is for one of the listed drugs
  • If Lyrica oral solution—patient has difficulty swallowing oral solids OR requires a dose not obtainable via capsules
  • Patient has achieved or maintained a positive clinical response to the requested drug

Approval duration

12 months